Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) S&P 500
5,308.13 +4.86 (+0.09%) Dow
39,806.77 -196.82 (-0.49%) Nasdaq
16,794.88 +108.91 (+0.65%) Bitcoin USD
71,313.08 +4,384.15 (+6.55%) CMC Crypto 200
1,541.11 +52.57 (+3.53%)
ASLAN Pharmaceuticals Limited (ASLN)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 0.4437 |
| Open | 0.4600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.4598 - 0.5393 |
| 52-week range | 0.3920 - 4.2600 |
| Volume | |
| Avg. volume | 1,259,041 |
| Market cap | 11.291M |
| Beta (5Y monthly) | 1.52 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
Here is how ASLAN Pharmaceuticals Ltd. (ASLN) and Assembly Biosciences (ASMB) have performed compared to their sector so far this year.
- Zacks
Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?
Here is how Aclaris Therapeutics (ACRS) and ASLAN Pharmaceuticals Ltd. (ASLN) have performed compared to their sector so far this year.
- Zacks
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
ASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with eczema, who have previously been treated with Dupixent but did not achieve an adequate response.
© 2024 Yahoo. All rights reserved.